Lupin launches Activella generic in US

Activella (estradiol and norethindrone acetate tablets), marketed by Amneal Pharmaceuticals, had annual sales of $ 91.1 million in the US, according to IMS Health

Capsules; Image Courtesy: Siegfried
BS B2B Bureau Mumbai
Last Updated : Nov 15 2016 | 2:29 PM IST
After receiving an approval from the US Food and Drug Administration (FDA), Lupin Limited has launched its Amabelz (estradiol and norethindrone acetate) tablets in two strengthens - 0.5 mg / 0.1 mg and 1 mg / 0.5 mg – in the US. Amabelz is the generic equivalent of Amneal Pharmaceuticals’ Activella tablet.

Amabelz tablets are indicated in a woman with a uterus for treatment of moderate to severe vasomotor symptoms due to menopause and prevention of postmenopausal osteoporosis. The tablet in strengthen of 1 mg / 0.5 mg is also indicated in a woman with a uterus for treatment of moderate to severe symptoms of vulvar and vaginal atrophy due to menopause.

Activella had US sales of $ 91.1 million, according to IMS MAT June 2016.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 15 2016 | 2:24 PM IST

Next Story